On Monday, Enfusion Inc (NYSE: ENFN) opened higher 3.65% from the last session, before settling in for the closing price of $8.76. Price fluctuations for ENFN have ranged from $7.52 to $10.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Technology Sector giant was 31.47%. Company’s average yearly earnings per share was noted 72.55% at the time writing. With a float of $49.35 million, this company’s outstanding shares have now reached $88.33 million.
Let’s determine the extent of company efficiency that accounts for 1102 employees. In terms of profitability, gross margin is 66.94%, operating margin of 3.4%, and the pretax margin is 3.86%.
Enfusion Inc (ENFN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Software – Application industry is another important factor to consider. The insider ownership of Enfusion Inc is 47.06%, while institutional ownership is 60.16%. The most recent insider transaction that took place on Sep 10 ’24, was worth 26,138. In this transaction Chief People Officer of this company sold 3,219 shares at a rate of $8.12, taking the stock ownership to the 195,694 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Officer proposed sale 3,219 for $8.12, making the entire transaction worth $26,153.
Enfusion Inc (ENFN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 72.55% per share during the next fiscal year.
Enfusion Inc (NYSE: ENFN) Trading Performance Indicators
Check out the current performance indicators for Enfusion Inc (ENFN). In the past quarter, the stock posted a quick ratio of 4.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.49. Likewise, its price to free cash flow for the trailing twelve months is 52.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.03, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.30 in one year’s time.
Technical Analysis of Enfusion Inc (ENFN)
Looking closely at Enfusion Inc (NYSE: ENFN), its last 5-days average volume was 0.25 million, which is a drop from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 39.58%. Additionally, its Average True Range was 0.25.
During the past 100 days, Enfusion Inc’s (ENFN) raw stochastic average was set at 53.65%, which indicates a significant decrease from 78.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 19.29% in the past 14 days, which was lower than the 33.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.58, while its 200-day Moving Average is $8.86. However, in the short run, Enfusion Inc’s stock first resistance to watch stands at $9.28. Second resistance stands at $9.48. The third major resistance level sits at $9.77. If the price goes on to break the first support level at $8.78, it is likely to go to the next support level at $8.49. Now, if the price goes above the second support level, the third support stands at $8.29.
Enfusion Inc (NYSE: ENFN) Key Stats
There are currently 128,110K shares outstanding in the company with a market cap of 846.35 million. Presently, the company’s annual sales total 174,540 K according to its annual income of 6,030 K. Last quarter, the company’s sales amounted to 49,460 K and its income totaled 1,830 K.
